Recombinant monoclonal antibody to CGRP. Fremanezumab is a humanized monoclonal antibody that can be potentially used in the treatment of Migraine. It binds to and inhibits the activity of CGRP.
Figure 1 Patient responses to questions concerning work/school/chore performance.
(A) Work/school performance: I worked/studied normally. (B) Best describe your ability to perform household chores: I performed household chores normally. CM = chronic migraine; HFEM = high-frequency episodic migraine. *p < 0.05, **p < 0.01, ***p < 0.001.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Please click here for more details about the introduction to mechanism of action, clinical projects and approved drugs of Fremanezumab